Related Experiment Video
Updated: Jun 7, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Adherence to antihypertensive agents and blood pressure control in chronic kidney disease
Kristen E Schmitt1, Christine F Edie, Paul Laflam
1Cincinnati Veterans Affairs Medical Center, University of Cincinnati, Cincinnati, Ohio 45220, USA.
Insights
Medication adherence in chronic kidney disease (CKD) is crucial for managing hypertension. Poor adherence to blood pressure medications is linked to uncontrolled hypertension, highlighting the need for improved monitoring in CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Hypertension is a significant, modifiable risk factor in chronic kidney disease (CKD).
- Medication adherence (MA) is essential for achieving blood pressure (BP) treatment goals in CKD patients.
- Current understanding of antihypertensive medication adherence patterns and their impact on BP in CKD settings is limited.
Purpose of the Study:
- To investigate patterns of medication adherence (MA) for antihypertensive agents in patients with chronic kidney disease (CKD).
- To determine the impact of MA on blood pressure (BP) control within CKD practice settings.
- To analyze the relationship between MA and BP levels in a large cohort of CKD patients.
Main Methods:
- A cohort of 7,227 CKD patients prescribed antihypertensive medications between 2006-2007 was analyzed.
- Medication adherence was assessed using the medication possession ratio (MPR).
- Logistic regression models were employed to examine the association between MA and BP control.
Main Results:
- 67% of patients exhibited good MA (MPR ≥ 0.8), with adherence varying by drug class.
- MPR significantly declined with worsening CKD stages (III, IV, V) and was negatively impacted by hospitalizations.
- Poor MA was independently associated with elevated BP (OR 1.23, 95% CI 1.11-1.37), with only 35% of patients achieving normal BP.
Conclusions:
- Approximately 33% of CKD patients demonstrate poor MA to antihypertensive medications.
- Medication adherence deteriorates as renal function declines in CKD patients.
- Improving MA monitoring and interventions in CKD care may lead to better hypertension management and patient outcomes.
Background:
hypertension is a modifiable risk factor in chronic kidney disease (CKD), and medication adherence (MA) is critical in reaching the treatment goals. Patterns of MA for antihypertensive agents and its impact on blood pressure (BP) in CKD practice settings are not well studied.
Methods:
we examined 7,227 CKD patients receiving at least one antihypertensive prescription between 2006 and 2007. Outpatient BP measurements were averaged as high (>130/ 80 mm Hg) versus normal (others). MA was calculated using medication possession ratio (MPR = actual treatment days/total possible treatment days). Good versus Poor MA (MPR ≥ 0.8 vs. <0.8) groups were compared for differences in demographic, co-morbid, and laboratory variables. The relationship between MA and BP was examined by logistic regression.
Results:
4,867/7,227 patients (67%) had Good MA; the frequency of patients with Good MA varied by each drug class (p < 0.0001). MPR declined with worsening CKD (stage III: MPR = 0.83 standard deviation (SD 0.18); stage IV: MPR = 0.78 (SD 0.22); stage V: MPR = 0.75 (SD 0.21); p < 0.0001). Hospitalization episodes also negatively impacted adherence. Only 35% of CKD patients had normal BP. By multivariate analysis, Poor MA was associated with high BP (odds ratio 1.23, 95% confidence interval 1.11-1.37).
Conclusions:
33% of CKD patients have Poor MA for antihypertensive agents, and MA worsens with declining renal function. Poor MA is associated with a 23% greater risk of uncontrolled hypertension. Monitoring and improving adherence in CKD practice may improve outcomes.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Hypertension and Regulation of Blood Pressure
Chronic Kidney Disease I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications
Acute Kidney Injury VI: Nursing Management
